Interferon-mediated NK cell activation is associated with limited neutralization breadth during SARS-CoV-2 infection
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 22, 2024
Abstract
Best
known
for
their
ability
to
kill
infected
or
malignant
cells,
natural
killer
(NK)
cells
are
also
underappreciated
regulators
of
the
antibody
response
viral
infection.
In
mice,
NK
can
T
follicular
helper
(Tfh)
decreasing
somatic
hypermutation
and
vaccine
responses.
Although
human
cell
activation
correlates
with
poor
response,
mechanisms
regulation
adaptive
immunity
poorly
understood.
We
found
that
in
ancestral
SARS-CoV-2
infection,
broad
neutralizers,
who
were
capable
neutralizing
Alpha,
Beta,
Delta,
had
fewer
expressed
inhibitory
immaturity
markers
whereas
from
narrow
neutralizers
highly
activated
interferon-stimulated
genes
(ISGs).
ISG-mediated
healthy
donors
increased
cytotoxicity
functional
responses
induced
Tfh-like
cells.
This
work
reveals
dysregulated
inflammation
may
play
a
role
opens
exciting
avenues
designing
improved
vaccines
adjuvants
target
emerging
pathogens.
Language: Английский
COVID-19 Lung Injury: Unique and Familiar Aspects of Pathophysiology
Applied Sciences,
Journal Year:
2024,
Volume and Issue:
14(23), P. 11048 - 11048
Published: Nov. 27, 2024
Acute
lung
injury
(ALI),
diagnosed
clinically
as
acute
respiratory
distress
syndrome
(ARDS),
refers
to
a
spectrum
of
inflammatory
processes
culminating
in
increased
permeability
the
pulmonary
alveolar–capillary
barrier
and
impaired
gas
exchange.
The
pandemic
caused
by
novel
coronavirus,
SARS-CoV-2,
has
raised
questions
similarities
differences
between
COVID-19
ALI
other
etiologies.
This
review
summarizes
current
knowledge
regarding
pathophysiology
draws
comparisons
latter
infectious
etiologies
ALI.
Indeed,
severe
is
characterized
unique
array
disease
mechanisms
including
suppression
interferon
responses,
widespread
inflammasome
activation,
altered
leukocyte
phenotypes,
hyperactive
thrombotic
activity.
Moreover,
these
manifest
clinical
progression,
which
further
differentiates
from
viral
pathogens
such
SARS,
MERS,
influenza.
These
features
bear
important
implications
for
future
therapeutic
strategies.
Language: Английский